IP Library Granted Patent US 10,562,839
Granted Patent B2
US 10,562,839 · App. 16/525,437 · Granted Feb 18, 2020

Medium chain fatty acid esters of β-hydroxybutyrate and butanediol and compositions and methods for using same

Inventors: Eric Verdin (Mill Valley, CA); Scott Michael Ulrich (Brooktondale, NY); John C. Newman (San Francisco, CA)
Assignees: The J. David Gladstone Institutes; The Regents of The University Of California; Ithaca College
C07C69/34A23L33/12A61P9/10A61P13/12A61P25/08A61P25/16A61P25/28A61P35/00A23V2002/00A23V2200/322A23V2250/54
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,562,839
App. No.
16/525,437
Granted
Feb 18, 2020
Kind
B2
Abstract

Aspects of the present disclosure include fatty acid β-hydroxyester compounds (e.g., fatty acid esters of β-hydroxybutyrate), fatty acid esters of butanediol, and pharmaceutically acceptable salts thereof. Also provided are pharmaceutical compositions having one or more fatty acid β-hydroxyester compounds and/or one or more fatty acid esters of butanediol. Methods for treating a subject by administering one or more esters to the subject are also provided. Kits containing one or more of the subject esters are also described.

Claims (36)

1. A compound of the formula:

or a compound of Formula II:

Formula II, and salts, solvates or hydrates thereof, wherein:

R 4 is H or C(1-6) alkyl or substituted alkyl; and

R 5 and R 6 are independently unsubstituted or substituted C(4-30) alkyl.

2. The compound of claim 1 , wherein said compound comprises a compound of Formula II.

3. The compound of claim 2 , wherein R 4 is an unsubstituted C(1-6) alkyl.

4. The compound of claim 3 , wherein R 4 is methyl.

5. The compound of claim 2 , wherein R 5 and R 6 are independently unsubstituted C(6-18) alkyl.

6. The compound of claim 2 , wherein R 5 and R 6 are independently unsubstituted C6 alkyl or independently unsubstituted C8 alkyl.

7. The compound of claim 2 , wherein the compound is a compound of Formula IIa:

Formula IIa.

8. The compound of claim 2 , wherein the compound is a compound of Formula

Formula IIb.

9. The compound of claim 1 , wherein said compound is a compound having the formula:

10. The compound of claim 1 , wherein said compound is a compound having the formula:

11. The compound of claim 1 , wherein said compound is a compound having the formula:

12. The compound of claim 1 , wherein said compound is a compound having the formula:

13. The compound of claim 1 , wherein said compound is a compound having the formula:

14. An oral preparation comprising one or more compounds of claim 1 and a preservative and/or a flavoring agent.

15. The oral preparation of claim 14 , wherein said preparation comprises water.

16. The oral preparation of claim 15 , wherein said preparation comprises a syrup or an elixir.

17. The oral preparation of claim 15 , wherein said preparation comprises a suspension.

18. The oral preparation of claim 14 , wherein said preparation comprises a binder.

19. The oral preparation of claim 18 , wherein said preparation comprises a binder selected from the group consisting of cellulose, methylcellulose, hydroxymethylcellulose, polypropylpyrrolidone, polyvinylpyrrolidone, gelatin, gum arabic, poly(ethylene glycol), sucrose, and starch.

20. The oral preparation of claim 14 , wherein said preparation comprises a flavoring agent.

21. The oral preparation of claim 20 , wherein said preparation comprises a flavoring agent selected from the group consisting of citric acid, menthol, glycine, and orange powder.

22. The oral preparation of claim 14 , wherein said preparation comprises a preservative.

23. The oral preparation of claim 22 , wherein said preparation comprises a preservative selected from the group consisting of sodium benzoate, sodium bisulflte, methylparaben, and propylparaben.

24. The oral preparation of claim 14 , wherein said compound comprises one or more compounds selected from the group consisting of

25. An ingestible composition comprising one or more compounds of claim 1 .

26. The ingestible composition of claim 25 , wherein said composition comprises a food supplemented with one or more of said compounds.

27. The ingestible composition of claim 25 , wherein said one or more compounds comprises one or more compounds selected from the group consisting of

28. A food supplement comprising one or more compounds of claim 1 .

29. The food supplement of claim 28 , wherein said food supplement comprises one or more additional components of a ketogenic diet.

30. The food supplement of claim 28 , wherein said compound comprises a compound selected from the group consisting of

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2020
From: VERDIN, ERIC
To: THE J. DAVID GLADSTONE INSTITUTES
Reel/Frame 052289/0566 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2020
From: ULRICH, SCOTT MICHAEL
To: ITHACA COLLEGE
Reel/Frame 052289/0570 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2020
From: NEWMAN, JOHN C.
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 052289/0627 →
Continuity (3)
Continuation 16306524
Provisional Application 62346975 · Jun 7, 2016
Related Publication 20190382333A1 · Dec 19, 2019
Cited By (1)
US 12,365,645